Canada Large Molecule Bioanalytical Testing Services Market Size & Outlook
Related Markets
Canada large molecule bioanalytical testing services market highlights
- The Canada large molecule bioanalytical testing services market generated a revenue of USD 91.1 million in 2024 and is expected to reach USD 141.2 million by 2030.
- The Canada market is expected to grow at a CAGR of 7.5% from 2025 to 2030.
- In terms of segment, clinical was the largest revenue generating phase in 2024.
- Preclinical is the most lucrative phase segment registering the fastest growth during the forecast period.
Large molecule bioanalytical testing services market data book summary
| Market revenue in 2024 | USD 91.1 million |
| Market revenue in 2030 | USD 141.2 million |
| Growth rate | 7.5% (CAGR from 2025 to 2030) |
| Largest segment | Clinical |
| Fastest growing segment | Preclinical |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Clinical, Preclinical |
| Key market players worldwide | Labcorp Holdings Inc, IQVIA Holdings Inc, Syneos Health, SGS AG, Toxikon, Intertek Group PLC, Pace Analytical Services, Icon PLC, Charles River Laboratories International Inc, Thermo Fisher Scientific Inc |
Other key industry trends
- In terms of revenue, Canada accounted for 4.3% of the global large molecule bioanalytical testing services market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. large molecule bioanalytical testing services market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 1,636.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Large Molecule Bioanalytical Testing Services Market Scope
Large Molecule Bioanalytical Testing Services Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Toxikon | View profile | 101-250 | Bedford, Massachusetts, United States, North America | http://www.toxikon.com/ |
| Pace Analytical Services | View profile | 11-50 | Woburn, Massachusetts, United States, North America | https://www.pacelifesciences.com |
| Syneos Health | View profile | 1001-5000 | Morrisville, North Carolina, United States, North America | https://www.syneoshealth.com/ |
| Intertek Group PLC | View profile | 44000 | 33 Cavendish Square, London, United Kingdom, W1G 0PS | https://www.intertek.com |
| SGS AG | View profile | 103193 | 1 Place des Alpes, P.O. Box 2152, Geneva, Switzerland, CH-1211 | https://www.sgs.com |
| IQVIA Holdings Inc | View profile | 87000 | 2400 Ellis Road, Durham, NC, United States, 27703 | https://www.iqvia.com |
| Icon PLC | View profile | 41150 | South County Business Park, Leopardstown, Dublin, Ireland, D18 X5R3 | https://www.iconplc.com |
| Labcorp Holdings Inc | View profile | 67000 | 358 South Main Street, Burlington, NC, United States, 27215 | https://www.labcorp.com |
| Charles River Laboratories International Inc | View profile | 21400 | 251 Ballardvale Street, Wilmington, MA, United States, 01887 | https://www.criver.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
Canada large molecule bioanalytical testing services market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to large molecule bioanalytical testing services market will help companies and investors design strategic landscapes.
Clinical was the largest segment with a revenue share of 71.24% in 2024. Horizon Databook has segmented the Canada large molecule bioanalytical testing services market based on clinical, preclinical covering the revenue growth of each sub-segment from 2018 to 2030.
Well-established healthcare infrastructure coupled with high healthcare expenditure in the country will boost market growth of large molecule bioanalytical testing in the country. For instance, according to Canadian Institute of Health Information, the total healthcare expenditure per person in Canada was USD 7,064 in 2019.
Such environment will augment the market for large molecule bioanalytical testing in the country. The biopharmaceutical pipeline of Canada covers various therapeutic fields, with innovative product candidates.
As of March 2017, there were around 158 biopharmaceutical small and medium enterprises offering more than 444 under development biopharmaceutical products for human health. Hence, robust biopharmaceutical product pipeline and suitable environment for clinical research are expected to augment market growth of large molecule bioanalytical testing.
Reasons to subscribe to Canada large molecule bioanalytical testing services market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Canada large molecule bioanalytical testing services market databook
-
Our clientele includes a mix of large molecule bioanalytical testing services market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada large molecule bioanalytical testing services market , including forecasts for subscribers. This country databook contains high-level insights into Canada large molecule bioanalytical testing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Canada large molecule bioanalytical testing services market size, by phase, 2018-2030 (US$M)
Canada Large Molecule Bioanalytical Testing Services Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
